fda glp-1 compounding warning letters september 2025 Beyond the Headlines: to Compounders The FDA has strictly clarified

"Injectable products are delivered directly into the body, sometimes directly into the bloodstream, and therefore, bypass some of the bodys key defenses against toxins and microorganisms that can lead to serious and life-threatening conditions

Epithalon exhibits dose-dependent antioxidant properties by upregulating key antioxidant enzymes including superoxide dismutase (SOD), glutathione peroxidase (GPX), and glutathione-S-transferase, providing cellular protection against oxidative stress

Catalase has been proven in studies to reduce inflammation and improve lung function in a variety of respiratory disorders, including COPD and asthma

Serious but rare risks include pancreatitis and gallbladder complications, which online providers screen for via intake questionnaires and medical history review

Already Lillys $1B and Roches effort suggest an AI arms race in pharma R&D